CDSCO approves Abbott’s proposal for Protocol Amendment of Triamcinolone Hexacetonide study
New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the protocol amendment proposal for the inclusion of 40 mg dose of Triamcinolone Hexatonide injectable suspension USP presented by the drug major Abbott for the synthetic glucocorticoid corticosteroid Triamcinolone hexacetonide. This came after Abbott presented the amendment […]